(Q40979921)

25 September 2017

title

Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production (English)

1 reference

25 September 2017

Baraz L

1

1 reference

25 September 2017

Friedler A

2

1 reference

25 September 2017

Blumenzweig I

3

1 reference

25 September 2017

Nussinuv O

4

1 reference

25 September 2017

Chen N

5

1 reference

25 September 2017

Steinitz M

6

1 reference

25 September 2017

Gilon C

7

1 reference

25 September 2017

Kotler M

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

441

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

419-426

1 reference

Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Conservation of amino-acid sequence motifs in lentivirus Vif proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

The sor gene of HIV-1 is required for efficient virus transmission in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

HIV-1 protease inhibitors. A review for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Point mutation in avian sarcoma leukaemia virus protease which increases its activity but impairs infectious virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Avian sarcoma leukemia virus protease linked to the adjacent Gag polyprotein is enzymatically active

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Synthetic peptides as substrates and inhibitors of a retroviral protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Complete nucleotide sequence of the AIDS virus, HTLV-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Rational design of peptide-based HIV proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

In vivo genetic variability of the HIV-1 vif gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901602-0

7 January 2021

10.1016/S0014-5793(98)01602-0

Identifiers

DOI

1 reference

25 September 2017

1 reference